Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility



Status:Enrolling by invitation
Conditions:Breast Cancer, Ovarian Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - 75
Updated:2/27/2019
Start Date:October 2015
End Date:July 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results

This non-therapeutic trial is for women who have received results of genetic testing for
BRCA1/2 mutations. The trial compares decision support tools designed to facilitate informed
decision making regarding risk management following testing to usual care. The researchers
will test separate decision support tools for women who receive positive test results and
women who receive negative/inconclusive test results. Among women who receive a positive test
result, an interactive decision support intervention will be compared to a print
intervention. Among women who receive an inconclusive result, an interactive intervention
will be compared to usual care.


Inclusion Criteria:

- Undergo BRCA1/2 genetic counseling and testing at one of four study sites

- Receive positive or uninformative test results

- English speaking

Exclusion Criteria:

- Newly diagnosed breast cancer patients who have not yet initiated definitive breast
cancer treatment

- Previous bilateral mastectomy
We found this trial at
1
site
Georgetown University Medical Center, Lombardi Comprehensive Cancer Center
Washington, District of Columbia 20007
?
mi
from
Washington,
Click here to add this to my saved trials